[Federal Register Volume 64, Number 178 (Wednesday, September 15, 1999)]
[Notices]
[Pages 50098-50099]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-24005]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[30 DAY-27-99]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7090. Send written 
comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
Executive Office Building, Room 10235; Washington, DC 20503. Written 
comments should be received within 30 days of this notice.

Proposed Project

    1. Aggregate report of follow-up for contacts of tuberculosis, and 
aggregate report of screening and preventive therapy for tuberculosis 
infection: two revised tuberculosis program management reports--New--
National Center for HIV, STD, and TB Prevention (NCHSTP)--To ensure the 
elimination of tuberculosis in the United States, key program 
activities such as finding tuberculosis infections in recent contacts 
of cases and in other persons likely to be infected, and providing 
prevention therapy, must be monitored. The Division of Tuberculosis 
Elimination (DTBE), is implementing two revised program management 
reports for annual submission: Aggregate report of follow-up for 
contacts of tuberculosis, and aggregate report of screening and 
preventive therapy of tuberculosis infection. The respondents for these 
reports are the 68 state and local tuberculosis control programs 
receiving federal cooperative agreement funding through (DTBE). The 
revised reports phase out two, twice-yearly program management reports 
in the Tuberculosis Statistics and Program Evaluation Activity (OMB 
0920-0026): Contact Follow-up (CDC 72.16) and Completion of Preventive 
Therapy (CDC 72.21). The revised reports, which are being submitted for 
an OMB approval outside of OMB 0920-0026, have several improvements 
over the old reports for the respondents and for DTBE, such as the 
emphasis on preventive therapy outcomes, the focus on high-priority 
target populations vulnerable to tuberculosis, and programmed 
electronic report generation and submission through the Tuberculosis 
Information Management System. The old reports, CDC 72.16 and

[[Page 50099]]

CDC 72.21, which have been submitted at least in some form by the 
respondents since 1961, are tabulated by hand.
    Three program management reports in the previous series already 
have been phased out. They are Bacteriologic Conversion of Sputum (CDC 
72.14), Case Register (CDC 72.15), and Drug Therapy (CDC 72.20). These 
three reports have been superseded by integrated reporting in 
Tuberculosis Statistics and Program Evaluation Activity (OMB 0920-
0026). The discontinuation of these reports has resulted in an 
estimated reduction in the annual response burden of 159 hours. The 
total annual burden hours are 136-340.

----------------------------------------------------------------------------------------------------------------
                                                                                       No of      Average burden
                             Report                                   No. of       responses per   per response
                                                                    respondents     respondent       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Aggregate report of follow-up for contacts of tuberculosis......              68               1             2.5
Aggregate report of screening and preventive therapy for TB                   68               1             2.5
 infection......................................................
----------------------------------------------------------------------------------------------------------------

    Date: September 9, 1999.
Nacy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 99-24005 Filed 9-14-99; 8:45 am]
BILLING CODE 4163-18-M